Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (24/11/2023) announced the following list of price concessions for November 2023.

Pack size
Price concession

Benzoyl peroxide 5% / Clindamycin 1% gel

Clotrimazole 1% cream

Co-codamol 15mg/500mg tablets

Cyclizine 50mg/1ml solution for injection ampoules

Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free

Glycopyrronium bromide 200micrograms/1ml solution for injection ampoules

Lamotrigine 5mg dispersible tablets sugar free

Letrozole 2.5mg tablets

Lofepramine 70mg tablets

Ondansetron 4mg tablets

Orlistat 120mg capsules

Pregabalin 225mg capsules

Prochlorperazine 3mg buccal tablets

Rasagiline 1mg tablets

Rizatriptan 10mg orodispersible tablets sugar free

Ropinirole 250microgram tablets

Sodium cromoglicate 2% eye drops

Terbinafine 1% cream

For the full list of price concessions granted so far for November 2023, please visit our webpage:

No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.

We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC. We are still working with the DHSC to agree concessionary prices for other drugs reported to be unavailable at the stated October Drug Tariff price. Please note that we cannot provide details of any generic products awaiting price concession approval from DHSC.

Please  subscribe to our mailing list to receive email updates of any price concessions.

Further information on price  concessions and FAQs about the process  involved  can be found on our website ( To hear more on how the current price  concessions system operates, pharmacy teams can now access a recording of our recent Medicines Supply and Concessions Briefing webinar  here.

Improvements to the price concession system

Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by  DHSC  in second half of 2022, it was agreed that an  urgent review of the price concession setting system would take place.

Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.

One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.

Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us. We are also continuing to work with DHSC on how a ‘retrospective increased payment’ may apply, where appropriate. Further information regarding this concession ‘top-up’ mechanism will be issued once details are finalised.

The post November 2023 Price Concessions 2nd Update appeared first on Community Pharmacy England.